SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000912057-15-000047
Filing Date
2015-02-20
Accepted
2015-02-20 17:07:02
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1646189
2 filename2.htm EX-10.26 23712
3 filename3.htm EX-10.27 216623
4 GRAPHIC g37792.jpg GRAPHIC 28405
5 GRAPHIC g37881.jpg GRAPHIC 13351
6 GRAPHIC g269462mmi001.gif GRAPHIC 9393
7 GRAPHIC g269462mmi002.gif GRAPHIC 11794
8 GRAPHIC g269462mmi003.jpg GRAPHIC 89611
9 GRAPHIC g269462mo03i001.jpg GRAPHIC 98985
10 GRAPHIC g269462mo03i002.jpg GRAPHIC 132633
11 GRAPHIC g269462mo05i001.jpg GRAPHIC 143968
12 GRAPHIC g354387.jpg GRAPHIC 37631
13 GRAPHIC g502234.jpg GRAPHIC 31658
14 GRAPHIC g570161.jpg GRAPHIC 40348
15 GRAPHIC g651536.jpg GRAPHIC 24567
16 GRAPHIC g672987.jpg GRAPHIC 41700
17 GRAPHIC g683899.jpg GRAPHIC 28062
18 GRAPHIC g979451.jpg GRAPHIC 21544
  Complete submission text file 0000912057-15-000047.txt   2928086
Mailing Address 900 SOUTH LIMESTONE STREET ROOM 459 LEXINGTON KY 40536
Business Address 900 SOUTH LIMESTONE STREET ROOM 459 LEXINGTON KY 40536 610-263-0163
Zynerba Pharmeceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-00903 | Film No.: 15636596
SIC: 2834 Pharmaceutical Preparations